2-(4-Isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid(CAS: 114311-32-9)

This compound falls under various regulatory guidelines including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and FDA and EPA requirements in the United States. It is essential to follow specific safety data sheets (SDS) for proper handling, storage, and disposal to ensure compliance with all relevant regulations.

Yes, there are alternative reagents and synthetic routes that can be used. For example, 4-methyl-4-isopropyl-3-oxo-3,4-dihydro-1H-imidazole and methoxyacetic acid can be used as starting materials. Additionally, isomers and analogs like 2-(4-tert-butyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid can also serve as viable alternatives.

The market for this compound is currently showing a steady growth trend, driven by increasing research in the pharmaceutical and biotechnology sectors. Recent studies indicate a growing interest in its potential applications in anti-inflammatory and antiviral therapies. Moreover, there is a significant trend towards developing more efficient and sustainable synthetic methods to produce this compound.

Waste containing this compound should be collected and disposed of in accordance with environmental protection regulations. It is recommended to use professional waste disposal services to ensure safe incineration or other appropriate methods. Proper safety measures, such as wearing protective gear and following local and international guidelines, should be strictly adhered to during the handling and disposal process.